Farms.com Home   News

US wheat wins, corn & soybeans sweat

Demand lifts wheat prices, but hot weather looms for key crops

By Farms.com

US wheat farmers have reason to celebrate after a positive day in the futures market. The price of wheat futures jumped on Friday, fueled by a confluence of favorable factors.

A weaker US dollar made American wheat more attractive to international buyers, and the arrival of a high-quality new harvest further boosted demand.

Adding to the positive sentiment, data released by the US Department of Agriculture revealed higher-than-expected wheat export sales for the upcoming marketing year. This suggests a strong global appetite for US wheat.

The outlook for other major US crops like corn and soybeans is less clear. The specter of hot and dry weather in July has cast a shadow over these crops, which require cooler temperatures and ample moisture during the crucial pollination stage. These conditions are essential for optimal yields, and their absence could lead to significant production shortfalls.

While overall trading volume remained subdued due to the recent US holiday and upcoming weekend, the price of wheat futures experienced a significant increase. September soft red winter wheat contracts closed up over 16 cents per bushel.

The price of corn and soybeans also saw modest gains, reflecting anxieties about the potential weather impact. However, these increases were smaller compared to the rise in wheat prices. Additionally, export sales data for both corn and soybeans fell short of expectations, adding to the uncertainty in these markets.

This situation underscores the inherent volatility of agricultural markets. While some crops benefit from favorable conditions and strong demand, others face potential threats from unpredictable weather patterns.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.